Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions
Standard
Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. / Tsang, Darren C; Azarrafiy, Ryan; Pecha, Simon; Reichenspurner, Hermann; Carrillo, Roger G; Hakmi, Samer.
in: HEART RHYTHM, Jahrgang 14, Nr. 12, 12.2017, S. 1833-1838.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions
AU - Tsang, Darren C
AU - Azarrafiy, Ryan
AU - Pecha, Simon
AU - Reichenspurner, Hermann
AU - Carrillo, Roger G
AU - Hakmi, Samer
N1 - Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
PY - 2017/12
Y1 - 2017/12
N2 - BACKGROUND: Many clinicians use the strategy of prophylactically placing an endovascular balloon before transvenous lead extraction, yet there are no data regarding this practice.OBJECTIVE: This study assesses long-term outcomes of prophylactic placement of an endovascular balloon in the venae cavae of patients during transvenous lead extraction.METHODS: From April 1, 2016 to March 31, 2017 data were prospectively collected at 2 international cardiovascular centers on patients who had the balloon prophylactically placed in the venae cavae. Patients were monitored for a minimum of 3 months to capture any associated adverse events.RESULTS: Twenty-one patients had the balloon prophylactically placed in the venae cavae during lead extraction. Sixteen patients were male (76%); the mean age was 57.6 ± 18.7 years; and the mean body mass index was 26.1 ± 4.4 kg/m2. The mean lead dwell time was 11.2 ± 8.3 years, with an average of 2.2 ± 1.1 leads per case, and most indications for extraction were noninfectious (62%). Two minor complications (10%, pocket hematomas) and 1 major complication (5%, cardiac tamponade) occurred during the procedure. All cases (100%) were procedural successes, and all patients (100%) were discharged alive. On follow-up (6.8 ± 3.7 months), all patients were alive and reported no adverse events related to prophylactic balloon placement, such as pulmonary emboli or deep venous thrombi.CONCLUSION: During the study period, we observed no acute or long-term adverse outcomes associated with prophylactic placement of an endovascular balloon in the venae cavae of patients undergoing transvenous lead extraction.
AB - BACKGROUND: Many clinicians use the strategy of prophylactically placing an endovascular balloon before transvenous lead extraction, yet there are no data regarding this practice.OBJECTIVE: This study assesses long-term outcomes of prophylactic placement of an endovascular balloon in the venae cavae of patients during transvenous lead extraction.METHODS: From April 1, 2016 to March 31, 2017 data were prospectively collected at 2 international cardiovascular centers on patients who had the balloon prophylactically placed in the venae cavae. Patients were monitored for a minimum of 3 months to capture any associated adverse events.RESULTS: Twenty-one patients had the balloon prophylactically placed in the venae cavae during lead extraction. Sixteen patients were male (76%); the mean age was 57.6 ± 18.7 years; and the mean body mass index was 26.1 ± 4.4 kg/m2. The mean lead dwell time was 11.2 ± 8.3 years, with an average of 2.2 ± 1.1 leads per case, and most indications for extraction were noninfectious (62%). Two minor complications (10%, pocket hematomas) and 1 major complication (5%, cardiac tamponade) occurred during the procedure. All cases (100%) were procedural successes, and all patients (100%) were discharged alive. On follow-up (6.8 ± 3.7 months), all patients were alive and reported no adverse events related to prophylactic balloon placement, such as pulmonary emboli or deep venous thrombi.CONCLUSION: During the study period, we observed no acute or long-term adverse outcomes associated with prophylactic placement of an endovascular balloon in the venae cavae of patients undergoing transvenous lead extraction.
KW - Catheterization, Peripheral/adverse effects
KW - Defibrillators, Implantable/adverse effects
KW - Device Removal/adverse effects
KW - Endovascular Procedures/methods
KW - Equipment Design
KW - Female
KW - Fluoroscopy
KW - Follow-Up Studies
KW - Germany/epidemiology
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Postoperative Complications/epidemiology
KW - Pulmonary Embolism/diagnostic imaging
KW - Retrospective Studies
KW - Risk Factors
KW - Surgery, Computer-Assisted/methods
KW - Time Factors
KW - United States/epidemiology
KW - Venae Cavae
U2 - 10.1016/j.hrthm.2017.08.003
DO - 10.1016/j.hrthm.2017.08.003
M3 - SCORING: Journal article
C2 - 28797678
VL - 14
SP - 1833
EP - 1838
JO - HEART RHYTHM
JF - HEART RHYTHM
SN - 1547-5271
IS - 12
ER -